Compare Intikeramik Alamasri Industri Tbk. (IKAI) vs Indofarma Tbk. (INAF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intikeramik Alamasri Industri Tbk. vs Indofarma Tbk. — how do they compare? Intikeramik Alamasri Industri Tbk. trades at Rp20 (market cap 279.42B, 10.68M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Indofarma Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| IKAI | INAF | |
|---|---|---|
Market Cap | 279.42B | 390.51B |
Volume | 10.68M | — |
Lot | 106.77K | — |
Turnover | 214.53M | — |
Average Price | 20.09 | — |
Value | 214.53M | — |
Indicative Equilibrium Price | 20 | — |
Indicative Equilibrium Volume | 10.92K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intikeramik Alamasri Industri Tbk.
PT Intikeramik Alamasri Industri Tbk (the Company) was established under the name PT Intikeramik Alamasri Indah based on notarial deed No. 38 dated June 26, 1991 and was amended with notarial deed No. 16 dated December 14, 1991, both made by Raden Muhammad Hendarmawan, S.H., Notary in Jakarta. PT Intikeramik Alamasri Industri Tbk is the pioneer of large-scale porcelain tile manufacture in Indonesia and one of the largest producers in the Asia Pacific region. Porcelain tiles are superior in term of strength, durability and design versatility to natural stone as well as other synthetics such as glazed tiles. Porcelain is attractive and affordable for use in both commercial and residential developments and has strong following among international architects and interior designers. Intikeramik is seeking to build a leading profile in markets across Europe, America and Asia drawing upon its reputation for consistency, advanced manufacturing technology, a low cost base and substantial available capacity. The company has consolidation production capacity 6,600,000 m2 /year.
Read more on IKAI →About Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →
